JPH0344320A - ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用 - Google Patents

ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用

Info

Publication number
JPH0344320A
JPH0344320A JP2175446A JP17544690A JPH0344320A JP H0344320 A JPH0344320 A JP H0344320A JP 2175446 A JP2175446 A JP 2175446A JP 17544690 A JP17544690 A JP 17544690A JP H0344320 A JPH0344320 A JP H0344320A
Authority
JP
Japan
Prior art keywords
tetrahydro
propenyl
naphthyl
phenol
tetramethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2175446A
Other languages
English (en)
Japanese (ja)
Inventor
Werner Bollag
ベルナー・ボラーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH0344320A publication Critical patent/JPH0344320A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2175446A 1989-07-06 1990-07-04 ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用 Pending JPH0344320A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH02520/89-5 1989-07-06
CH252089 1989-07-06

Publications (1)

Publication Number Publication Date
JPH0344320A true JPH0344320A (ja) 1991-02-26

Family

ID=4235631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2175446A Pending JPH0344320A (ja) 1989-07-06 1990-07-04 ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用

Country Status (9)

Country Link
EP (1) EP0407788A3 (OSRAM)
JP (1) JPH0344320A (OSRAM)
KR (1) KR910002434A (OSRAM)
AU (1) AU5861690A (OSRAM)
CA (1) CA2017956A1 (OSRAM)
HU (1) HUT54298A (OSRAM)
IE (1) IE902438A1 (OSRAM)
IL (1) IL94942A0 (OSRAM)
ZA (1) ZA905125B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202500A (ja) * 1984-03-27 1985-10-12 松下電器産業株式会社 音素認識方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083891B1 (es) * 1991-04-24 1997-01-16 Univ Valencia Estudi General Procedimiento de obtencion de derivados del 2-(1-propenil) fenol.
ES2248901T3 (es) * 1997-05-14 2006-03-16 Atherogenics, Inc. Monoesteres de probucol para el tratamiento de trastornos cardiovasculares e inflamatorios.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
ZW6587A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche Tetrahydro naphthanline derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202500A (ja) * 1984-03-27 1985-10-12 松下電器産業株式会社 音素認識方法

Also Published As

Publication number Publication date
HUT54298A (en) 1991-02-28
IL94942A0 (en) 1991-06-10
AU5861690A (en) 1991-01-10
EP0407788A2 (de) 1991-01-16
HU904053D0 (OSRAM) 1990-12-28
KR910002434A (ko) 1991-02-25
CA2017956A1 (en) 1991-01-06
EP0407788A3 (en) 1991-05-15
IE902438A1 (en) 1991-06-19
ZA905125B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
CA2620380C (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
CN103327992B (zh) 用于预防或治疗炎性疾病的包含络石藤提取物和牡丹皮提取物的药物组合物以及制备该药物组合物的方法
JPH06504543A (ja) 中枢ドパミン欠乏状態を治療するための経口投与可能な医薬製剤
JP2009196905A (ja) カンカニクジュヨウから得られる肝保護剤及び抗ＴＮＦ−α作用剤
KR20090043115A (ko) 감태에서 추출한 플로로탄닌을 함유하는 아토피 질환의치료 또는 예방용 조성물
JP2025510813A (ja) Ｔｙｋ２阻害剤及びその使用
WO2024183784A1 (zh) 托品酸及其衍生物在制备免疫与炎症相关疾病治疗药物中的医药用途
JPH0344320A (ja) ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用
JPH06234636A (ja) インターロイキン８を阻害するためのレフルノミドの使用
JPS58174313A (ja) 動物組織の線維化抑制剤
TWI435727B (zh) 調節細胞激素分泌之用途
EP0944612B1 (en) N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
JPS58206524A (ja) 抗腫瘍剤
JPH10287582A (ja) 樹皮抽出物からなるヒスタミン遊離抑制剤
JPS5855423A (ja) ベンゾグアナミン類を主成分としする医薬
KR100912735B1 (ko) 루틴 함유 괴화 추출물을 유효성분으로 하는 소염 진통제조성물
EP0476391B1 (en) Anti-AIDS virus composition containing cepharanthine as active compound
JP2013227256A (ja) 血管内皮機能改善剤
EP1607091B1 (en) Antihepatitis c virus agent and anti-hiv agent
KR100953177B1 (ko) 항염증 및 면역억제 효과를 갖는 레스베라트롤 유도체 화합물 및 이를 함유하는 약학적 조성물
AU757489B2 (en) Method for inhibiting cytokine production by cells
JPH04202126A (ja) インターロイキン―１産生抑制剤
JPS61145118A (ja) 免疫調節剤
JPS6165819A (ja) 有機ゲルマニウム化合物を含有する薬剤組成物
JPS63216884A (ja) リウマチ性関節炎治療剤